Beranda › Kanker (semua jenis) › Texas › Austin
Uji klinis Kanker (semua jenis) di Austin, TX
20 studi untuk Kanker (semua jenis) mencari peserta di lokasi sekitar Austin (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
Menerima pesertaFase 2
- Texas Oncology-Austin North /ID# 279958, Austin
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Menerima pesertaFase 3
- Texas Oncology, Austin
A Study of NEOK001, a B7-H3 and ROR1 Targeting Bispecific ADC in Participants With Select Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, Austin
Prospective Study to Assess a Diagnostic Aid for Cancer
Menerima pesertaStudi observasional
- Premier Family Physicians, Austin
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Menerima pesertaFase 2
- Dell Medical School, University of Texas at Austin, Austin
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
Menerima pesertaFase 1/2
- NEXT Oncology ( Site 1010), Austin
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Menerima pesertaFase 1
- NEXT Oncology - Austin, Austin
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Menerima pesertaFase 3
- USO - Texas Oncology, Austin
Project: Every Child for Younger Patients With Cancer
Menerima pesertaStudi observasional
- Dell Children's Medical Center of Central Texas, Austin
A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- Texas Oncology - Central South, Austin
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
Menerima pesertaFase 1
- Texas Oncology - Central/South Texas /ID# 268563, Austin
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Menerima pesertaFase 2
- Texas Oncology - Central/South Texas /ID# 275154, Austin
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
Menerima pesertaFase 2/3
- Texas Oncology - South Austin /ID# 276033, Austin
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
Menerima pesertaFase 2
- Texas Oncology - Austin Central, Austin
A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)
Menerima pesertaFase 1
- GSK Investigational Site, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology Austin, Austin
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Menerima pesertaFase 1/2
- NEXT Oncology, Austin
Beat Childhood Cancer Specimen Banking and Data Registry
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Dell Children's Blood and Cancer Center, Austin
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
Menerima pesertaFase 1/2
- NEXT Austin, Austin
A Study in Patients With Advanced Cancers
Menerima pesertaFase 1/2
- NEXT Oncology Austin, Austin
Uji klinis Kanker (semua jenis) di kota lain
- Houston, TX121 studi
- New York City, NY110 studi
- Boston, MA86 studi
- Los Angeles, CA73 studi
- Nashville, TN65 studi
- Philadelphia, PA59 studi
- Durham, NC58 studi
- Washington, DC58 studi
- Chicago, IL51 studi
- Seattle, WA49 studi
- Atlanta, GA49 studi
- Arlington, VA48 studi
Studi lain di Austin
- Kanker Paru Non-Sel Kecil30 studi
- Obesitas20 studi
- Kanker Metastatik19 studi
- Kanker Kolorektal19 studi
- Gagal Jantung18 studi
- Kanker Payudara18 studi
- Kelebihan Berat Badan18 studi
- Kanker Ovarium17 studi
- Kanker Endometrium15 studi
- Kanker Prostat15 studi
- Depresi14 studi
- Kanker Payudara Triple-Negatif13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.